The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Endocrine Testing System-Global Market Insights and Sales Trends 2024
Synopsis
The global Endocrine Testing System market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Endocrine Testing System in various end use industries. The expanding demands from the Hospitals, Commercial Laboratories, Ambulatory Care Centres and Other Setting, are propelling Endocrine Testing System market. Tandem Mass Spectrometry, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the LC-MS/MS segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Endocrine Testing System market, driven by demand from China, the second largest economy with some signs of stabilising, the Endocrine Testing System market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Endocrine Testing System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Endocrine Testing System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Endocrine Testing System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Endocrine Testing System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Endocrine Testing System covered in this report include Abbott Laboratories, AdnaGen, Beckman Coulter/Danaher, Biomedical Diagnostics, BioMerieux, Bio-Rad, DiaSorin, Fujirebio and Instrumentation Laboratory, etc.
The global Endocrine Testing System market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
AdnaGen
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Fujirebio
Instrumentation Laboratory
Kyowa Medex
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Danaher (AB Sciex)
Agilent Technologies
Bio Rad Laboratories
LabCorp
Quest Diagnostics
Global Endocrine Testing System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Endocrine Testing System market, Segment by Type:
Tandem Mass Spectrometry
LC-MS/MS
Immunoassay
Monoclonal & Polyclonal antibody technologies
Sensor technology
Clinical chemistry
Others
Global Endocrine Testing System market, by Application
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Endocrine Testing System companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Endocrine Testing System market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Endocrine Testing System in various end use industries. The expanding demands from the Hospitals, Commercial Laboratories, Ambulatory Care Centres and Other Setting, are propelling Endocrine Testing System market. Tandem Mass Spectrometry, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the LC-MS/MS segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Endocrine Testing System market, driven by demand from China, the second largest economy with some signs of stabilising, the Endocrine Testing System market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Endocrine Testing System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Endocrine Testing System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Endocrine Testing System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Endocrine Testing System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Endocrine Testing System covered in this report include Abbott Laboratories, AdnaGen, Beckman Coulter/Danaher, Biomedical Diagnostics, BioMerieux, Bio-Rad, DiaSorin, Fujirebio and Instrumentation Laboratory, etc.
The global Endocrine Testing System market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
AdnaGen
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Fujirebio
Instrumentation Laboratory
Kyowa Medex
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Danaher (AB Sciex)
Agilent Technologies
Bio Rad Laboratories
LabCorp
Quest Diagnostics
Global Endocrine Testing System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Endocrine Testing System market, Segment by Type:
Tandem Mass Spectrometry
LC-MS/MS
Immunoassay
Monoclonal & Polyclonal antibody technologies
Sensor technology
Clinical chemistry
Others
Global Endocrine Testing System market, by Application
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Endocrine Testing System companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Endocrine Testing System
1.1 Endocrine Testing System Market Overview
1.1.1 Endocrine Testing System Product Scope
1.1.2 Endocrine Testing System Market Status and Outlook
1.2 Global Endocrine Testing System Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Endocrine Testing System Market Size by Region (2018-2029)
1.4 Global Endocrine Testing System Historic Market Size by Region (2018-2023)
1.5 Global Endocrine Testing System Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Endocrine Testing System Market Size (2018-2029)
1.6.1 North America Endocrine Testing System Market Size (2018-2029)
1.6.2 Europe Endocrine Testing System Market Size (2018-2029)
1.6.3 Asia-Pacific Endocrine Testing System Market Size (2018-2029)
1.6.4 Latin America Endocrine Testing System Market Size (2018-2029)
1.6.5 Middle East & Africa Endocrine Testing System Market Size (2018-2029)
2 Endocrine Testing System Market by Type
2.1 Introduction
2.1.1 Tandem Mass Spectrometry
2.1.2 LC-MS/MS
2.1.3 Immunoassay
2.1.4 Monoclonal & Polyclonal antibody technologies
2.1.5 Sensor technology
2.1.6 Clinical chemistry
2.1.7 Others
2.2 Global Endocrine Testing System Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Endocrine Testing System Historic Market Size by Type (2018-2023)
2.2.2 Global Endocrine Testing System Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Endocrine Testing System Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Endocrine Testing System Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Endocrine Testing System Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Endocrine Testing System Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Endocrine Testing System Revenue Breakdown by Type (2018-2029)
3 Endocrine Testing System Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Commercial Laboratories
3.1.3 Ambulatory Care Centres
3.1.4 Other Setting
3.2 Global Endocrine Testing System Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Endocrine Testing System Historic Market Size by Application (2018-2023)
3.2.2 Global Endocrine Testing System Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Endocrine Testing System Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Endocrine Testing System Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Endocrine Testing System Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Endocrine Testing System Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Endocrine Testing System Revenue Breakdown by Application (2018-2029)
4 Endocrine Testing System Competition Analysis by Players
4.1 Global Endocrine Testing System Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Endocrine Testing System as of 2022)
4.3 Date of Key Players Enter into Endocrine Testing System Market
4.4 Global Top Players Endocrine Testing System Headquarters and Area Served
4.5 Key Players Endocrine Testing System Product Solution and Service
4.6 Competitive Status
4.6.1 Endocrine Testing System Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Endocrine Testing System Products, Services and Solutions
5.1.4 Abbott Laboratories Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 AdnaGen
5.2.1 AdnaGen Profile
5.2.2 AdnaGen Main Business
5.2.3 AdnaGen Endocrine Testing System Products, Services and Solutions
5.2.4 AdnaGen Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.2.5 AdnaGen Recent Developments
5.3 Beckman Coulter/Danaher
5.3.1 Beckman Coulter/Danaher Profile
5.3.2 Beckman Coulter/Danaher Main Business
5.3.3 Beckman Coulter/Danaher Endocrine Testing System Products, Services and Solutions
5.3.4 Beckman Coulter/Danaher Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.3.5 Biomedical Diagnostics Recent Developments
5.4 Biomedical Diagnostics
5.4.1 Biomedical Diagnostics Profile
5.4.2 Biomedical Diagnostics Main Business
5.4.3 Biomedical Diagnostics Endocrine Testing System Products, Services and Solutions
5.4.4 Biomedical Diagnostics Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.4.5 Biomedical Diagnostics Recent Developments
5.5 BioMerieux
5.5.1 BioMerieux Profile
5.5.2 BioMerieux Main Business
5.5.3 BioMerieux Endocrine Testing System Products, Services and Solutions
5.5.4 BioMerieux Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.5.5 BioMerieux Recent Developments
5.6 Bio-Rad
5.6.1 Bio-Rad Profile
5.6.2 Bio-Rad Main Business
5.6.3 Bio-Rad Endocrine Testing System Products, Services and Solutions
5.6.4 Bio-Rad Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.6.5 Bio-Rad Recent Developments
5.7 DiaSorin
5.7.1 DiaSorin Profile
5.7.2 DiaSorin Main Business
5.7.3 DiaSorin Endocrine Testing System Products, Services and Solutions
5.7.4 DiaSorin Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.7.5 DiaSorin Recent Developments
5.8 Fujirebio
5.8.1 Fujirebio Profile
5.8.2 Fujirebio Main Business
5.8.3 Fujirebio Endocrine Testing System Products, Services and Solutions
5.8.4 Fujirebio Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.8.5 Fujirebio Recent Developments
5.9 Instrumentation Laboratory
5.9.1 Instrumentation Laboratory Profile
5.9.2 Instrumentation Laboratory Main Business
5.9.3 Instrumentation Laboratory Endocrine Testing System Products, Services and Solutions
5.9.4 Instrumentation Laboratory Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.9.5 Instrumentation Laboratory Recent Developments
5.10 Kyowa Medex
5.10.1 Kyowa Medex Profile
5.10.2 Kyowa Medex Main Business
5.10.3 Kyowa Medex Endocrine Testing System Products, Services and Solutions
5.10.4 Kyowa Medex Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.10.5 Kyowa Medex Recent Developments
5.11 Ortho-Clinical Diagnostics
5.11.1 Ortho-Clinical Diagnostics Profile
5.11.2 Ortho-Clinical Diagnostics Main Business
5.11.3 Ortho-Clinical Diagnostics Endocrine Testing System Products, Services and Solutions
5.11.4 Ortho-Clinical Diagnostics Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.11.5 Ortho-Clinical Diagnostics Recent Developments
5.12 Roche
5.12.1 Roche Profile
5.12.2 Roche Main Business
5.12.3 Roche Endocrine Testing System Products, Services and Solutions
5.12.4 Roche Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.12.5 Roche Recent Developments
5.13 Siemens
5.13.1 Siemens Profile
5.13.2 Siemens Main Business
5.13.3 Siemens Endocrine Testing System Products, Services and Solutions
5.13.4 Siemens Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.13.5 Siemens Recent Developments
5.14 Sysmex
5.14.1 Sysmex Profile
5.14.2 Sysmex Main Business
5.14.3 Sysmex Endocrine Testing System Products, Services and Solutions
5.14.4 Sysmex Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.14.5 Sysmex Recent Developments
5.15 Thermo Fisher
5.15.1 Thermo Fisher Profile
5.15.2 Thermo Fisher Main Business
5.15.3 Thermo Fisher Endocrine Testing System Products, Services and Solutions
5.15.4 Thermo Fisher Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.15.5 Thermo Fisher Recent Developments
5.16 Tosoh
5.16.1 Tosoh Profile
5.16.2 Tosoh Main Business
5.16.3 Tosoh Endocrine Testing System Products, Services and Solutions
5.16.4 Tosoh Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.16.5 Tosoh Recent Developments
5.17 Danaher (AB Sciex)
5.17.1 Danaher (AB Sciex) Profile
5.17.2 Danaher (AB Sciex) Main Business
5.17.3 Danaher (AB Sciex) Endocrine Testing System Products, Services and Solutions
5.17.4 Danaher (AB Sciex) Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.17.5 Danaher (AB Sciex) Recent Developments
5.18 Agilent Technologies
5.18.1 Agilent Technologies Profile
5.18.2 Agilent Technologies Main Business
5.18.3 Agilent Technologies Endocrine Testing System Products, Services and Solutions
5.18.4 Agilent Technologies Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.18.5 Agilent Technologies Recent Developments
5.19 Bio Rad Laboratories
5.19.1 Bio Rad Laboratories Profile
5.19.2 Bio Rad Laboratories Main Business
5.19.3 Bio Rad Laboratories Endocrine Testing System Products, Services and Solutions
5.19.4 Bio Rad Laboratories Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.19.5 Bio Rad Laboratories Recent Developments
5.20 LabCorp
5.20.1 LabCorp Profile
5.20.2 LabCorp Main Business
5.20.3 LabCorp Endocrine Testing System Products, Services and Solutions
5.20.4 LabCorp Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.20.5 LabCorp Recent Developments
5.21 Quest Diagnostics
5.21.1 Quest Diagnostics Profile
5.21.2 Quest Diagnostics Main Business
5.21.3 Quest Diagnostics Endocrine Testing System Products, Services and Solutions
5.21.4 Quest Diagnostics Endocrine Testing System Revenue (US$ Million) & (2018-2023)
5.21.5 Quest Diagnostics Recent Developments
6 North America
6.1 North America Endocrine Testing System Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Endocrine Testing System Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Testing System Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Endocrine Testing System Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Testing System Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Endocrine Testing System Market Dynamics
11.1 Endocrine Testing System Industry Trends
11.2 Endocrine Testing System Market Drivers
11.3 Endocrine Testing System Market Challenges
11.4 Endocrine Testing System Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
